• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰变加速因子抑制补体C3激活并延缓低密度脂蛋白受体缺陷小鼠的动脉粥样硬化进程。

Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.

作者信息

Leung Viola W Y, Yun Sheng, Botto Marina, Mason Justin C, Malik Talat H, Song Wenchao, Paixao-Cavalcante Danielle, Pickering Matthew C, Boyle Joseph J, Haskard Dorian O

机构信息

Vascular Science Section, Imperial College, National Heart and Lung Institute, the Division of Investigative Sciences, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom.

出版信息

Am J Pathol. 2009 Oct;175(4):1757-67. doi: 10.2353/ajpath.2009.090183. Epub 2009 Sep 3.

DOI:10.2353/ajpath.2009.090183
PMID:19729477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2751570/
Abstract

Decay-accelerating factor (DAF; CD55) is a membrane protein that regulates complement pathway activity at the level of C3. To test the hypothesis that DAF plays an essential role in limiting complement activation in the arterial wall and protecting from atherosclerosis, we crossed DAF gene targeted mice (daf-1(-/-)) with low-density lipoprotein-receptor deficient mice (Ldlr(-/-)). Daf-1(-/-)Ldlr(-/-) mice had more extensive en face Sudan IV staining of the thoracoabdominal aorta than Ldlr(-/-) mice, both following a 12-week period of low-fat diet or a high-fat diet. Aortic root lesions in daf-1(-/-)Ldlr(-/-) mice on a low-fat diet showed increased size and complexity. DAF deficiency increased deposition of C3d and C5b-9, indicating the importance of DAF for downstream complement regulation in the arterial wall. The acceleration of lesion development in the absence of DAF provides confirmation of the proinflammatory and proatherosclerotic potential of complement activation in the Ldlr(-/-) mouse model. Because upstream complement activation is potentially protective, this study underlines the importance of DAF in shielding the arterial wall from the atherogenic effects of complement.

摘要

衰变加速因子(DAF;CD55)是一种膜蛋白,可在C3水平调节补体途径活性。为了验证DAF在限制动脉壁补体激活和预防动脉粥样硬化中起关键作用这一假说,我们将DAF基因靶向小鼠(daf-1(-/-))与低密度脂蛋白受体缺陷小鼠(Ldlr(-/-))进行杂交。在低脂饮食或高脂饮食12周后,daf-1(-/-)Ldlr(-/-)小鼠胸腹主动脉的苏丹IV整体染色比Ldlr(-/-)小鼠更广泛。低脂饮食的daf-1(-/-)Ldlr(-/-)小鼠主动脉根部病变的大小和复杂性增加。DAF缺陷增加了C3d和C5b-9的沉积,表明DAF对动脉壁下游补体调节的重要性。在缺乏DAF的情况下病变发展加速,证实了Ldlr(-/-)小鼠模型中补体激活的促炎和促动脉粥样硬化潜力。由于上游补体激活可能具有保护作用,本研究强调了DAF在保护动脉壁免受补体致动脉粥样硬化作用方面的重要性。

相似文献

1
Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice.衰变加速因子抑制补体C3激活并延缓低密度脂蛋白受体缺陷小鼠的动脉粥样硬化进程。
Am J Pathol. 2009 Oct;175(4):1757-67. doi: 10.2353/ajpath.2009.090183. Epub 2009 Sep 3.
2
Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.简短报告:缺乏膜结合补体调节蛋白CD59的低密度脂蛋白受体缺陷小鼠中动脉粥样硬化加速
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1714-6. doi: 10.1161/ATVBAHA.108.169912. Epub 2008 Jul 10.
3
The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice.替代途径对于低密度脂蛋白受体缺陷小鼠内毒素和饮食诱导的动脉粥样硬化中的致病补体激活至关重要。
Circulation. 2010 Nov 9;122(19):1948-56. doi: 10.1161/CIRCULATIONAHA.110.981365. Epub 2010 Oct 25.
4
Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.衰变加速因子而非CD59限制实验性免疫复合物性肾小球肾炎。
Lab Invest. 2007 Apr;87(4):357-64. doi: 10.1038/labinvest.3700522. Epub 2007 Jan 29.
5
Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.Crry,而非CD59和衰变加速因子(DAF),对于小鼠红细胞在体内免受自发补体攻击至关重要。
Blood. 2002 May 15;99(10):3707-16. doi: 10.1182/blood.v99.10.3707.
6
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.基因靶向揭示衰变加速因子在调节红细胞表面补体激活中的作用。
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):628-33. doi: 10.1073/pnas.96.2.628.
7
Decay-accelerating factor induction by tumour necrosis factor-alpha, through a phosphatidylinositol-3 kinase and protein kinase C-dependent pathway, protects murine vascular endothelial cells against complement deposition.肿瘤坏死因子-α通过磷脂酰肌醇-3激酶和蛋白激酶C依赖性途径诱导衰变加速因子,可保护小鼠血管内皮细胞免受补体沉积。
Immunology. 2003 Oct;110(2):258-68. doi: 10.1046/j.1365-2567.2003.01733.x.
8
Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall.衰变加速因子调节人类动脉粥样硬化壁中补体介导的损伤。
Immunol Lett. 1990 Oct;26(1):17-23. doi: 10.1016/0165-2478(90)90170-u.
9
Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.补体介导的红细胞清除:Crry和衰变加速因子(DAF)的机制及调节作用的描述。衰变加速因子。
Blood. 2002 Dec 15;100(13):4544-9. doi: 10.1182/blood-2002-06-1875. Epub 2002 Aug 1.
10
CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.CD59而非衰变加速因子(DAF)的缺乏会加速雌性载脂蛋白E基因敲除小鼠的动脉粥样硬化进程。
Mol Immunol. 2009 May;46(8-9):1702-9. doi: 10.1016/j.molimm.2009.02.009. Epub 2009 Mar 17.

引用本文的文献

1
Canonical and non-canonical roles of complement in atherosclerosis.补体在动脉粥样硬化中的经典和非经典作用。
Nat Rev Cardiol. 2024 Nov;21(11):743-761. doi: 10.1038/s41569-024-01016-y. Epub 2024 Apr 10.
2
Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis.补体因子 H 通过细胞自主调控补体 C3 限制巨噬细胞噬作用并加剧动脉粥样硬化。
Immunity. 2023 Aug 8;56(8):1809-1824.e10. doi: 10.1016/j.immuni.2023.06.026. Epub 2023 Jul 26.
3
New insight of complement system in the process of vascular calcification.补体系统在血管钙化过程中的新认识。
J Cell Mol Med. 2023 May;27(9):1168-1178. doi: 10.1111/jcmm.17732. Epub 2023 Apr 1.
4
Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery.针对丙二醛修饰的低密度脂蛋白的稳态抗体耗竭与大血管手术中的不良事件相关。
Antioxidants (Basel). 2022 Jan 29;11(2):271. doi: 10.3390/antiox11020271.
5
Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase.二甲双胍通过造血腺苷单磷酸激活蛋白激酶直接抑制血糖正常小鼠的动脉粥样硬化。
Cardiovasc Res. 2021 Apr 23;117(5):1295-1308. doi: 10.1093/cvr/cvaa171.
6
Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1.体内血肿的消退受激活转录因子 1 调控。
Circ Res. 2020 Sep 11;127(7):928-944. doi: 10.1161/CIRCRESAHA.119.315528. Epub 2020 Jul 1.
7
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Human Medium- and Large-Sized Arteries.CD90 鉴定成年人大中动脉的外膜间充质祖细胞。
Stem Cell Reports. 2018 Jul 10;11(1):242-257. doi: 10.1016/j.stemcr.2018.06.001. Epub 2018 Jun 28.
8
Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.慢性肾脏病患者的内皮细胞微颗粒与全身补体激活。
J Am Heart Assoc. 2018 Jul 13;7(14):e007818. doi: 10.1161/JAHA.117.007818.
9
Complement proteins and arterial calcification in middle aged women: Cross-sectional effect of cardiovascular fat. The SWAN Cardiovascular Fat Ancillary Study.中年女性中的补体蛋白与动脉钙化:心血管脂肪的横断面效应。SWAN心血管脂肪辅助研究。
Atherosclerosis. 2015 Dec;243(2):533-9. doi: 10.1016/j.atherosclerosis.2015.10.095. Epub 2015 Oct 24.
10
The role of complement activation in atherogenesis: the first 40 years.补体激活在动脉粥样硬化发生中的作用:最初的40年。
Immunol Res. 2016 Feb;64(1):1-13. doi: 10.1007/s12026-015-8669-6.

本文引用的文献

1
Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.甘露糖结合凝集素在巨噬细胞中的特异性表达可控制低密度脂蛋白受体缺陷小鼠的动脉粥样硬化。
Circulation. 2009 Apr 28;119(16):2188-95. doi: 10.1161/CIRCULATIONAHA.108.830661. Epub 2009 Apr 20.
2
CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice.CD59而非衰变加速因子(DAF)的缺乏会加速雌性载脂蛋白E基因敲除小鼠的动脉粥样硬化进程。
Mol Immunol. 2009 May;46(8-9):1702-9. doi: 10.1016/j.molimm.2009.02.009. Epub 2009 Mar 17.
3
Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex.补体调节蛋白CD59通过限制补体膜攻击复合物的形成来预防动脉粥样硬化。
Circ Res. 2009 Feb 27;104(4):550-8. doi: 10.1161/CIRCRESAHA.108.191361. Epub 2009 Jan 8.
4
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice.T细胞活化导致Apoe(-/-)小鼠动脉粥样硬化斑块中胶原蛋白成熟度降低。
Am J Pathol. 2009 Feb;174(2):693-700. doi: 10.2353/ajpath.2009.080561. Epub 2009 Jan 8.
5
The role of complement in atherosclerosis.补体在动脉粥样硬化中的作用。
Curr Opin Lipidol. 2008 Oct;19(5):478-82. doi: 10.1097/MOL.0b013e32830f4a06.
6
Brief report: accelerated atherosclerosis in low-density lipoprotein receptor-deficient mice lacking the membrane-bound complement regulator CD59.简短报告:缺乏膜结合补体调节蛋白CD59的低密度脂蛋白受体缺陷小鼠中动脉粥样硬化加速
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1714-6. doi: 10.1161/ATVBAHA.108.169912. Epub 2008 Jul 10.
7
KLF2-dependent, shear stress-induced expression of CD59: a novel cytoprotective mechanism against complement-mediated injury in the vasculature.KLF2依赖的切应力诱导的CD59表达:一种针对血管系统中补体介导损伤的新型细胞保护机制。
J Biol Chem. 2008 May 23;283(21):14636-44. doi: 10.1074/jbc.M800362200. Epub 2008 Mar 24.
8
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.在缺乏补体因子H的小鼠中,补体因子I是膜增生性肾小球肾炎发生所必需的。
J Clin Invest. 2008 Feb;118(2):608-18. doi: 10.1172/JCI32525.
9
C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice.C1酯酶抑制剂可预防易患动脉粥样硬化小鼠动脉损伤后的新生内膜形成。
Circulation. 2008 Jan 1;117(1):70-8. doi: 10.1161/CIRCULATIONAHA.107.715649. Epub 2007 Dec 10.
10
The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain.动脉粥样硬化啮齿动物模型的结果不可互换:饮食和品系的影响。
Atherosclerosis. 2007 Dec;195(2):e85-92. doi: 10.1016/j.atherosclerosis.2007.06.012. Epub 2007 Jul 24.